Group 6 Copy 261
0
    Please wait...

    About This Project

    Therapeutics in any modality to combat Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections are in urgent demand across the entire world as the Coronavirus Disease 2019 (COVID-19) pandemic continues to interrupt the well-being of human life. Without clinical therapeutics available for any of the human coronaviruses, a key starting point is to focus on target-based high-throughput screening (HTS) to reveal potent anti-SARS-CoV-2 hit-to-leads that are safe to human cells.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Developing a low-cost, rapid diagnostic for urogenital Schistosomiasis infection

    We are developing a frugal diagnostic for urogenital schistosomiasis, a neglected tropical disease that...

    Working towards a low-cost ostomy bag that doesn't leak

    Ostomy bags are a daily medical necessity for 15 million people globally. However, these bags often delaminate...

    A robust and clinical-friendly CRISPR diagnostic test kit for rapid SARS-COV2 detection

    The high specificity and sensitivity of the CRISPR diagnostics, e.g. SHERLOCK, can detect the presence of...

    Backer Badge Funded

    A medicine project funded by 16 people